BioCentury | Apr 26, 2004
Company News

GeneProt, Lundbeck deal

...from a rodent model of CNS disease. LUN will have exclusive rights to commercialize results. GeneProt Inc....
BioCentury | Apr 22, 2004
Company News

GeneProt, Lundbeck CNS proteomics deal

GeneProt (Geneva, Switzerland) will use its MicroProt process to study the proteomics of fluid samples taken from a rodent model of CNS disease. Lundbeck (CSE:LUN) will have exclusive rights to commercialize results. BC Staff...
BioCentury | Feb 16, 2004
Company News

GeneProt, Novartis deal

...2000 proteomics deal (see BioCentury, Oct. 23, 2000). As expanded, GeneProt will provide pharmacoproteomics services. GeneProt Inc....
BioCentury | Jun 2, 2003
Company News

GeneProt, Novartis deal

...protein under its 2002 deal with GeneProt (see BioCentury, Sept. 9, 2002). Under the deal, GeneProt...
...proteins of interest and NVS will further develop the proteins. Under a separate 2000 deal, GeneProt...
...fluids and their healthy counterparts that were selected by NVS (see BioCentury, Oct. 23, 2000). GeneProt Inc....
BioCentury | Apr 7, 2003
Company News

GeneProt proteomics news

...Proteomics service company GeneProt said it is planning to reduce its headcount to 50 from 95...
...from its analysis and bioinformatics departments in a move to reduce the company's burn rate. GeneProt Inc....
BioCentury | Apr 3, 2003
Company News

GeneProt planning staff reductions

...Proteomics service company GeneProt (Zurich, Switzerland) said it is planning to reduce its headcount to 50...
BioCentury | Mar 17, 2003
Company News

GeneProt management update

...Geneva, Switzerland Business: Proteomics Promoted: Bertrand Damour to CEO and a director from co-chairman of GeneProt's...
BioCentury | Mar 11, 2003
Company News

GeneProt promotes Damour to CEO

...Proteomics company GeneProt (Geneva, Switzerland) promoted Bertrand Damour to CEO and a director. Prior, he was...
...Switzerland) promoted Bertrand Damour to CEO and a director. Prior, he was from co-chairman of GeneProt's...
BioCentury | Jan 27, 2003
Company News

GeneProt, Serono S.A deal

...SEO will test a set of polypeptides and proteins discovered and chemically synthesized by GeneProt. SEO...
...SEO has an option to obtain an exclusive license to any of the peptides supplied. GeneProt Inc....
BioCentury | Jan 21, 2003
Company News

Serono, GeneProt protein deal

...SRA will test a set of polypeptides and proteins discovered and chemically synthesized by GeneProt (Bridgewater...
...option to obtain an exclusive license to any of the polypeptides and proteins supplied by GeneProt...
Items per page:
1 - 10 of 25
BioCentury | Apr 26, 2004
Company News

GeneProt, Lundbeck deal

...from a rodent model of CNS disease. LUN will have exclusive rights to commercialize results. GeneProt Inc....
BioCentury | Apr 22, 2004
Company News

GeneProt, Lundbeck CNS proteomics deal

GeneProt (Geneva, Switzerland) will use its MicroProt process to study the proteomics of fluid samples taken from a rodent model of CNS disease. Lundbeck (CSE:LUN) will have exclusive rights to commercialize results. BC Staff...
BioCentury | Feb 16, 2004
Company News

GeneProt, Novartis deal

...2000 proteomics deal (see BioCentury, Oct. 23, 2000). As expanded, GeneProt will provide pharmacoproteomics services. GeneProt Inc....
BioCentury | Jun 2, 2003
Company News

GeneProt, Novartis deal

...protein under its 2002 deal with GeneProt (see BioCentury, Sept. 9, 2002). Under the deal, GeneProt...
...proteins of interest and NVS will further develop the proteins. Under a separate 2000 deal, GeneProt...
...fluids and their healthy counterparts that were selected by NVS (see BioCentury, Oct. 23, 2000). GeneProt Inc....
BioCentury | Apr 7, 2003
Company News

GeneProt proteomics news

...Proteomics service company GeneProt said it is planning to reduce its headcount to 50 from 95...
...from its analysis and bioinformatics departments in a move to reduce the company's burn rate. GeneProt Inc....
BioCentury | Apr 3, 2003
Company News

GeneProt planning staff reductions

...Proteomics service company GeneProt (Zurich, Switzerland) said it is planning to reduce its headcount to 50...
BioCentury | Mar 17, 2003
Company News

GeneProt management update

...Geneva, Switzerland Business: Proteomics Promoted: Bertrand Damour to CEO and a director from co-chairman of GeneProt's...
BioCentury | Mar 11, 2003
Company News

GeneProt promotes Damour to CEO

...Proteomics company GeneProt (Geneva, Switzerland) promoted Bertrand Damour to CEO and a director. Prior, he was...
...Switzerland) promoted Bertrand Damour to CEO and a director. Prior, he was from co-chairman of GeneProt's...
BioCentury | Jan 27, 2003
Company News

GeneProt, Serono S.A deal

...SEO will test a set of polypeptides and proteins discovered and chemically synthesized by GeneProt. SEO...
...SEO has an option to obtain an exclusive license to any of the peptides supplied. GeneProt Inc....
BioCentury | Jan 21, 2003
Company News

Serono, GeneProt protein deal

...SRA will test a set of polypeptides and proteins discovered and chemically synthesized by GeneProt (Bridgewater...
...option to obtain an exclusive license to any of the polypeptides and proteins supplied by GeneProt...
Items per page:
1 - 10 of 25